Trials / Completed
CompletedNCT00211601
Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041)
Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,500 (planned)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess whether timely feedback to providers on patient experiences with delayed chemotherapy induced nausea and vomiting (CINV) lead to differences in patient outcomes for subsequent cycles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Disease Management Assessment |
Timeline
- Start date
- 2004-08-01
- Primary completion
- 2005-12-01
- Completion
- 2005-12-01
- First posted
- 2005-09-21
- Last updated
- 2015-05-01
Source: ClinicalTrials.gov record NCT00211601. Inclusion in this directory is not an endorsement.